loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 210455 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE (1)

filter

01 JANSSEN PRODS (1)

filter

01 TABLET;ORAL (1)

filter

01 150MG;800MG;200MG;EQ 10MG BASE (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET;ORAL
150MG;800MG;200MG;EQ 1...
SYMTUZA
USA
210455
2018-07-17
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 210455

Looking for CTD TGA MCC DOSSIER APPLICATION 210455 1

19

Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE, with a corresponding application number 210455 and regulatory information .

proudly manufactured in the

approval since 2018-07-17

Johnson & Johnson Innovative Medicine's SYMTUZA TABLET;ORAL, medication with 150MG;800MG;200MG;EQ 10MG BASE of COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE.

Post Enquiry
POST ENQUIRY